<em>Mycobacterium tuberculosis</em> Pathogenesis, Infection Prevention and Treatment
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
English[eng]
Mycobacterium tuberculosis||line probe assay||second-line drugs||drug resistance||XDR-TB||MDR-TB||omics analysis||TB treatment||system analysis||Beijing B0/W148||Mycobacterium smegmatis||imidazo[1,2-b][1,2,4,5]tetrazine||MmpS5-MmpL5||efflux||drug discovery||tuberculosis||immune activation||HLA-DR||CD38||treatment response||Mycobacterium||macrophage||apoptosis||effector||cytokine||microRNA||Beijing genotype||Central Asia Outbreak||murine infection model||Virulence||pre-XDR-TB||Mycobacterium avium||unique metabolic pathways||subtractive genomics||drug target||uncharacterized proteins||BM-MSCs||Mtb||bone-homing||stem cell niche||latent tuberculosis||relapse||liposomes||M. tuberculosis||host-pathogen interactions||immune response||antitubercular drug discovery||antitubercular treatments||IL-18||IL-18BP||IL-18R||gene expression
English[eng]
Mycobacterium tuberculosis||line probe assay||second-line drugs||drug resistance||XDR-TB||MDR-TB||omics analysis||TB treatment||system analysis||Beijing B0/W148||Mycobacterium smegmatis||imidazo[1,2-b][1,2,4,5]tetrazine||MmpS5-MmpL5||efflux||drug discovery||tuberculosis||immune activation||HLA-DR||CD38||treatment response||Mycobacterium||macrophage||apoptosis||effector||cytokine||microRNA||Beijing genotype||Central Asia Outbreak||murine infection model||Virulence||pre-XDR-TB||Mycobacterium avium||unique metabolic pathways||subtractive genomics||drug target||uncharacterized proteins||BM-MSCs||Mtb||bone-homing||stem cell niche||latent tuberculosis||relapse||liposomes||M. tuberculosis||host-pathogen interactions||immune response||antitubercular drug discovery||antitubercular treatments||IL-18||IL-18BP||IL-18R||gene expression